Overview GIP Receptor Antagonist Studies in Humans Status: Completed Trial end date: 2016-07-01 Target enrollment: Participant gender: Summary Antagonizing GIP effects during hyperglycaemia in healthy subjects and measurements of insulin secretion. Phase: N/A Details Lead Sponsor: University Hospital, Gentofte, CopenhagenCollaborator: University of CopenhagenTreatments: Gastric Inhibitory Polypeptide